The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantation

Arnon Nagler, Bhagirathbhai Dholaria*, Myriam Labopin, Gerard Socie, Anne Huynh, Maija Itälä-Remes, Eric Deconinck, Ibrahim Yakoub-Agha, Jean Yves Cahn, Jean Henri Bourhis, Hélène Labussière-Wallet, Sylvain Chantepie, Jordi Esteve, Bipin Savani, Mohamad Mohty

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences